Endocyte

Activity by year

201820192020202120222023202420252026

AcquisitionContract

Dec 20, 2018ACQUISITIONUnited States$2.00B
Novartis completes $2B acquisition of Endocyte
Novartis AG completed its acquisition of Endocyte Inc. for $24 per share in cash, totaling approximately $2 billion. The deal was originally announced on October 17, 2018.
Novartis acquirer Endocyte target #Medical Devices uk.marketscreener.com
Jul 9, 2018CONTRACT$5.80M
Endocyte and ITM sign long-term supply agreement for Lutetium-177
Endocyte and ITM subsidiary ITG signed a long-term global supply agreement for no-carrier-added Lutetium-177 (EndolucinBeta) to support clinical and commercial supply of 177Lu-PSMA-617 through 2035. Endocyte will pay €5 million upfront to support ITM's expansion of manufacturing capacity.
Endocyte customer ITM Isotopen Technologien München supplier Isotope Technologies Garching supplier #Specialty Chemicals itm-radiopharma.com

Suppliers

Acquired by

Loading…